Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Apotex Inc. et al v. Lupin Ltd. et al
Case Number:
2:15-cv-00599
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 12, 2016
Apotex, Lupin Settle Paxil Infringement Fight
Apotex Inc. and rival Lupin Ltd. have settled their patent infringement suit over the antidepressant drug Paxil pursuant to undisclosed terms, according to a Texas federal judge who dismissed the suit Friday.
-
December 01, 2015
Lupin Says 'Sensitive' Docs Are Irrelevant In Paxil Fight
Apotex Inc. is using a jurisdictional fight with rival Lupin Ltd. in a patent infringement suit over the antidepressant drug Paxil to request unrelated documents that contain sensitive commercial information, Lupin told a Texas federal court Monday.
-
November 06, 2015
Apotex Wants Lupin Docs In Patent Suit Jurisdiction Row
Canadian drug company Apotex Inc. asked a judge Thursday to force Lupin Ltd. to hand over certain documents related to its drug sales, saying the information could show the rivals' patent case over the antidepressant Paxil belongs in Texas federal court.
-
May 04, 2015
Lupin Smacked With IP Suit Over Generic Paxil
Apotex Inc. has gone to court to prevent Lupin Ltd. from selling a generic version of the popular antidepressant drug Paxil, telling a Texas federal court judge that allowing Lupin to move forward would infringe a patent owned by Apotex.